Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K
Division of Cardiology, Kumamoto University School of Medicine, Japan.
Circulation. 1993 Jul;88(1):82-91. doi: 10.1161/01.cir.88.1.82.
Brain natriuretic peptide is a novel natriuretic peptide that is secreted predominantly from the ventricles, and its plasma levels have been shown to be markedly increased in patients with chronic congestive heart failure. This study was designed to examine the plasma levels of brain natriuretic peptide as well as atrial natriuretic peptide in patients with acute myocardial infarction.
We examined the plasma levels of brain natriuretic peptide as well as atrial natriuretic peptide in 50 consecutive patients (36 men and 14 women; mean age, 66 years) with acute myocardial infarction over the time course of 4 weeks. The plasma level of brain natriuretic peptide was significantly increased on admission in patients with acute myocardial infarction compared with controls (92 +/- 28 versus 5.2 +/- 0.5 pg/mL, P < .01) and reached the peak level of 319 +/- 58 pg/mL at 16.4 +/- 0.7 hours after admission. Thereafter, the level decreased and then again increased, forming the second peak of 277 +/- 66 pg/mL on day 5. The level then decreased gradually but was still much higher in the fourth week than that of controls (149 +/- 47 versus 5.2 +/- 0.5 pg/mL, P < .001). On the other hand, the plasma atrial natriuretic peptide level already had been increased at the time of admission compared with controls (116 +/- 14 versus 39.5 +/- 2.6 pg/mL, P < .01) and decreased thereafter, again increasing and making a small peak on day 2 to 3. The time course of the plasma brain natriuretic peptide level could be divided into two patterns: a monophasic pattern with one peak at about 16 hours after admission and a biphasic pattern with two peaks at about 16 hours and 5 days after admission. There were significantly more patients with anterior infarction, congestive heart failure, higher level of maximal creatine kinase-MB isoenzyme, and lower left ventricular ejection fraction in the biphasic group than in the monophasic group.
We conclude that the plasma level of brain natriuretic peptide is increased markedly in patients with acute myocardial infarction and may reflect the degree of left ventricular dysfunction in these patients.
脑钠肽是一种主要由心室分泌的新型利钠肽,慢性充血性心力衰竭患者的血浆水平已显示显著升高。本研究旨在检测急性心肌梗死患者的脑钠肽以及心房钠尿肽的血浆水平。
我们检测了50例连续的急性心肌梗死患者(36例男性和14例女性;平均年龄66岁)在4周时间内的脑钠肽以及心房钠尿肽的血浆水平。与对照组相比,急性心肌梗死患者入院时脑钠肽血浆水平显著升高(92±28对5.2±0.5 pg/mL,P<.01),并在入院后16.4±0.7小时达到峰值水平319±58 pg/mL。此后,该水平下降,然后再次升高,在第5天形成第二个峰值277±66 pg/mL。然后该水平逐渐下降,但在第4周时仍比对照组高得多(149±47对5.2±0.5 pg/mL,P<.001)。另一方面,与对照组相比,入院时血浆心房钠尿肽水平就已升高(116±14对39.5±2.6 pg/mL,P<.01),此后下降,在第2至3天再次升高并形成一个小峰值。血浆脑钠肽水平的时间进程可分为两种模式:单相模式,在入院后约16小时有一个峰值;双相模式,在入院后约16小时和5天有两个峰值。双相组中前壁梗死、充血性心力衰竭、最大肌酸激酶-MB同工酶水平较高以及左心室射血分数较低的患者明显多于单相组。
我们得出结论,急性心肌梗死患者的脑钠肽血浆水平显著升高,可能反映了这些患者左心室功能障碍的程度。